 |
PDBsum entry 4s0s
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
4s0s
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
427:924-942
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Developing Adnectins that target SRC co-activator binding to PXR: a structural approach toward understanding promiscuity of PXR.
|
|
J.A.Khan,
D.M.Camac,
S.Low,
A.J.Tebben,
D.L.Wensel,
M.C.Wright,
J.Su,
V.Jenny,
R.D.Gupta,
M.Ruzanov,
K.A.Russo,
A.Bell,
Y.An,
J.W.Bryson,
M.Gao,
P.Gambhire,
E.T.Baldwin,
D.Gardner,
C.L.Cavallaro,
J.V.Duncia,
J.Hynes.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The human pregnane X receptor (PXR) is a promiscuous nuclear receptor that
functions as a sensor to a wide variety of xenobiotics and regulates expression
of several drug metabolizing enzymes and transporters. We have generated
"Adnectins", derived from 10th fibronectin type III domain ((10)Fn3),
that target the PXR ligand binding domain (LBD) interactions with the steroid
receptor co-activator-1 (SRC-1) peptide, displacing SRC-1 binding. Adnectins are
structurally homologous to the immunoglobulin superfamily. Three different
co-crystal structures of PXR LBD with Adnectin-1 and CCR1 (CC chemokine
receptor-1) antagonist Compound-1 were determined. This structural information
was used to modulate PXR affinity for a related CCR1 antagonist compound that
entered into clinical trials for rheumatoid arthritis. The structures of PXR
with Adnectin-1 reveal specificity of Adnectin-1 in not only targeting the
interface of the SRC-1 interactions but also engaging the same set of residues
that are involved in binding of SRC-1 to PXR. Substituting SRC-1 with Adnectin-1
does not alter the binding conformation of Compound-1 in the ligand binding
pocket. The structure also reveals the possibility of using Adnectins as
crystallization chaperones to generate structures of PXR with compounds of
interest.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|